8-KThe WireStrategic
Results of Operations · Reg FD Disclosure
Filed Aug 4, 2022 · 3y ago · Accession 0001564590-22-027893
Plain English
Material event — a significant development the company must disclose promptly.
Read the source below for the full document.
Filing details
- Company
- Spyre Therapeutics, Inc.
- Ticker
- SYRE
- CIK
- 1636282
- Form type
- 8-K
- Filing date
- Aug 4, 2022
- Report date
- Aug 4, 2022
- Document
- agle-8k_20220804.htm
- Size
- 10.6 MB